5,7-dinitroquinoxaline-2,3-dione has been researched along with gamma-glutamylglutamate in 1 studies
| Studies (5,7-dinitroquinoxaline-2,3-dione) | Trials (5,7-dinitroquinoxaline-2,3-dione) | Recent Studies (post-2010) (5,7-dinitroquinoxaline-2,3-dione) | Studies (gamma-glutamylglutamate) | Trials (gamma-glutamylglutamate) | Recent Studies (post-2010) (gamma-glutamylglutamate) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 8 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akerman, KE; Holopainen, I; Janáky, R; Oja, SS; Varga, V | 1 |
1 other study(ies) available for 5,7-dinitroquinoxaline-2,3-dione and gamma-glutamylglutamate
| Article | Year |
|---|---|
Endogenous gamma-L-glutamylglutamate is a partial agonist at the N-methyl-D-aspartate receptors in cultured cerebellar granule cells.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium; Cells, Cultured; Cerebellum; Dipeptides; Drug Synergism; Glutamates; Glutamic Acid; Glycine; Magnesium; N-Methylaspartate; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1995 |